
Sign up to save your podcasts
Or


AstraZeneca’s vaccine gets UK approval, but the FDA has yet to decide. Bill Barker analyzes that story, reacts to 2021 precitions about the price of oil and a return to domestic travel, and shares why future investors might not realize how crazy 2020 was for the stock market.
By The Motley Fool4.7
16041,604 ratings
AstraZeneca’s vaccine gets UK approval, but the FDA has yet to decide. Bill Barker analyzes that story, reacts to 2021 precitions about the price of oil and a return to domestic travel, and shares why future investors might not realize how crazy 2020 was for the stock market.

3,228 Listeners

1,498 Listeners

807 Listeners

938 Listeners

518 Listeners

1,173 Listeners

2,175 Listeners

825 Listeners

1,416 Listeners

1,044 Listeners

9,722 Listeners

196 Listeners

828 Listeners

82 Listeners

597 Listeners

989 Listeners

53 Listeners